External quality assessment scheme for Bordetella pertussis serology 2016
This external quality assessment (EQA) to assess the ability of national reference laboratories from EU/EEA Member States to correctly perform laboratory serodiagnostic tests for pertussis was a collaborative study organised from February to April 2016.
Pertussis - Annual Epidemiological Report 2015
In 2015, 40 195 cases of pertussis were reported by 29 EU/EEA countries.
Pertussis - Annual Epidemiological Report 2016 [2014 data]
In 2014, 40 727 cases of pertussis were reported to TESSy by 29 EU/EEA countries. The notification rate was 9.1 cases per 100 000 population, higher than in 2013, but lower than in the epidemic year of 2012.
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA - 1st update, 3 February 2016
This Rapid Risk Assessment focuses on acellular pertussis-containing combination vaccines used in national vaccination programmes in the EU/EEA Member States.
Rapid Risk Assessment: Shortage of acellular pertussis-containing vaccines and impact on immunisation programmes in the EU/EEA, 13 October 2015
Early in 2015, a shortage of acellular pertussis-containing vaccines was brought to the attention of ECDC. This risk assessment provides a detailed list of mitigation options available to Member States.